Early and late complications of totally implantable venous access devices

Journal of Surgical Oncology
K J Grannan, P H Taylor

Abstract

We reviewed the records of 66 consecutive patients who underwent placement of totally implantable venous access devices (TIVADs). Fourteen patients (21%) experienced complications related to the TIVAD. Complications included hematoma, infection, pneumothorax, subclavian vein thrombosis, and chronic clavicular pain. The 1 month mortality rate following insertion of a TIVAD was 24% (16 of 66 patients); however, none of the patients died as a direct consequence of port insertion or its associated complications. Overall patient and physician acceptance of TIVADs was good, and we encourage continued use and study of this device.

References

Nov 1, 1987·Archives of Surgery·G V StanislavJ B Feole
Oct 1, 1986·Journal of Surgical Oncology·R E WellingJ J Arbaugh
Nov 1, 1986·American Journal of Surgery·A G Wile
Apr 1, 1984·American Journal of Surgery·A BotheJ J Lokich

❮ Previous
Next ❯

Citations

Nov 1, 1995·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J M DebetsJ T Schlangen
Sep 17, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·L LaurenziE Arcuri
Feb 15, 2001·AIDS Patient Care and STDs·P Domingo, A Fontanet
Feb 19, 2013·Clinical Radiology·M NayeemuddinJ R Asquith
Apr 6, 2004·Journal of Vascular and Interventional Radiology : JVIR·Steven C WagnerKevin L Sullivan
Jul 8, 2009·Journal of Surgical Oncology·Hasan Karanlik, Sidika Kurul
Jun 15, 2011·Journal of Surgical Oncology·Nikolaos BarbetakisChristodoulos Tsilikas
Feb 1, 1992·The Journal of Hospital Infection·A Johnson, B A Oppenheim
Oct 1, 1994·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·K RubleS Brown
Mar 28, 2018·The Journal of Vascular Access·İlknur YıldırımHasan Karanlık
Jul 7, 2005·Journal of Surgical Oncology·Shaw-Min HouYa-Hui Chen
Mar 21, 2020·Irish Journal of Medical Science·Mehmet Emin InceSuat Doganci
Sep 30, 2009·World Journal of Gastroenterology : WJG·Ching-Chuan HsiehChia-Siu Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.